Summary
Cytokines and chemokines play significant roles in the recruitment of leucocytes from the circulation and are therefore crucial determinants of inflammatory reactions and immunity. As knowledge of the actions of these agents and their regulatory mechanisms increases, so does the opportunity to devise pharmacological means of intervening in the activities of these molecules. It is now believed, for instance, that the actions of the classical pro-inflammatory cytokine interleukin (IL)-1 are inhibited by the expression and presentation of a ‘decoy’ receptor, which acts as a ‘molecular trap’ for IL-1. There is evidence to suggest that IL-6, formerly considered a purely anti-inflammatory cytokine, also has proinflammatory properties. Furthermore, regulation of the chemokine system, which can be achieved by regulating agonist production or altering the expression of chemokine receptors, has recently been demonstrated. These and other new findings, which may prove to have considerable relevance as regards current or future strategies for the treatment of inflammation, infection, neoplasia etc., are presented and discussed in this article.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Stylianou E, O’Neill LA, Rawlinson L, et al. Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes. J Biol Chem 1992; 267: 15836–41
Colotta F, Sironi M, Borre A, et al. Type II interleukin-1 receptor is not expressed in cultured endothelial cells and is not involved in endothelial cell activation. Blood 1993; 81: 1347–51
Iwasaki T, Sims JE, Grabstein K, et al. Comparison of IL-1 alpha effectiveness in activating murine pre-B-cell and T-cell lines. Cytokine 1993; 5: 416–26
Colotta F, Re F, Muzio R, et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993; 261: 472–5
Re F, Muzio M, De Rossi M, et al. The type II ‘receptor’ as a decoy target for interleukin 1 in polymorphonuclear leukocytes. J Exp Med 1994; 179: 739–43
Colotta F, Re F, Muzio M, et al. Interleukin-13 induces expression and release of interleukin decoy receptor in human polymorphonuclear cells. J Biol Chem 1994; 269: 12403–6
Alcami A, Smith GL. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 1992; 71: 153–67
Spriggs MK, Hruby DE, Maliszewski CR, et al. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 1992; 71: 145–52
Re F, Sironi M, Muzio M, et al. Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface “receptor” with anti-interleukin-1 function. J Exp Med 1996; 183: 1841–50
Re F, Muzio M, De Rossi M, et al. The type II “receptor” as a decoy target for IL-1 in polymorphonuclear leukocytes: characterization of induction by dexamethazone and ligand binding properties of the released decoy receptor. J Exp Med 1994; 179: 739–43
Romano M, Sironi M, Toniatti C, et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997; 6: 315–25
Sironi M, Breviario F, Proserpio P, et al. IL-1 stimulates IL-6 production in endothelial cells. J Immunol 1989; 142: 549–53
Luini W, De Rossi M, Licciardello L, et al. Chemotactic cytokine gene expression and production induced in human monocytes by membrane proteoglycans from Klebsiella pneumoniae. Int J Immunopharm 1991; 13: 631–7
Sica A, Saccani A, Borsatti A, et al. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med 1997; 185: 969–74
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mantovani, A. The Interplay between Primary and Secondary Cytokines. Drugs 54 (Suppl 1), 15–23 (1997). https://doi.org/10.2165/00003495-199700541-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199700541-00006